Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Protective Effect of Pilin Protein With Alum+Naloxone Adjuvant Against Acute Pulmonary Pseudomonas Aeruginosa Infection Publisher Pubmed



Banadkoki AZ1, 2 ; Keshavarzmehr M2 ; Afshar Z1 ; Aleyasin N1 ; Fatemi MJ3 ; Behrouz B3, 4 ; Hashemi FB4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Quality Control Department of Iran Gelatin Capsule Mfg. Co., Tehran, Iran
  3. 3. Burn Research Center, Hazrat Fatima Hospital, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Biologicals Published:2016


Abstract

Pseudomonas aeruginosa is an important opportunistic human pathogen that causes a wide variety of severe nosocomial infections. Type IV pili of P. aeruginosa are made up of polymerized pilin that aids in bacterial adhesion, biofilm formation and twitching motility. The aim of this study was to evaluate the efficacy of alum and naloxone (alum+NLX) as an adjuvant for P. aeruginosa recombinant PilA (r-PilA) as a vaccine candidate in the improvement of humoral and cellular immunity. Primary immunization with r-PilA in combination with alum+NLX followed by two booster shots was sufficient to generate robust cellular and humoral responses, which were Th1 and Th2 type responses consisting of IgG1 and IgG2a subtypes. Analysis of the cytokine response among immunized mice showed an increased production of IL-4, INF-γ and IL-17 by splenocytes upon stimulation by r-PilA. These sera were also able to reduce bacterial load in the lung tissue of challenged mice. The reduction of systemic bacterial spread resulted in increased survival rates in challenged immunized mice. In conclusion, immunization with r-PilA combined with alum+NLX evokes cellular and humoral immune responses, which play an important role in providing protection against acute P. aeruginosa lung infection among immunized mice. © 2016 International Alliance for Biological Standardization
Related Docs
View other Related Docs
1. Flagellin and Pilin Immunization Against Multi-Drug Resistant Pseudomonas Aeruginosa Protects Mice in the Burn Wound Sepsis Model, Immunology Letters (2016)
2. Immunogenicity and Protective Efficacy of Pseudomonas Aeruginosa Type a and B Flagellin Vaccines in a Burned Mouse Model, Molecular Immunology (2016)
3. Immunization With Bivalent Flagellin Protects Mice Against Fatal Pseudomonas Aeruginosa Pneumonia, Journal of Immunology Research (2017)
4. A Trivalent Vaccine Consisting of “Flagellin A+B and Pilin” Protects Against Pseudomonas Aeruginosa Infection in a Murine Burn Model, Microbial Pathogenesis (2020)
5. Antibodies Raised Against Divalent Type B Flagellin and Pilin Provide Effective Immunotherapy Against Pseudomonas Aeruginosa Infection of Mice With Burn Wounds, Biologicals (2017)
6. Passive Immunization Against Pseudomonas Aeruginosa Recombinant Pila in a Murine Burn Wound Model, Microbial Pathogenesis (2016)
7. Administration of Naloxone in Combination With Recombinant Plasmodium Vivax Ama-1 in Balb/C Mice Induces Mixed Th1/Th2 Immune Responses, Parasite Immunology (2015)
8. Cloning, Expression, and Purification of Pseudomonas Aeruginosa Flagellin, and Characterization of the Elicited Anti-Flagellin Antibody, Iranian Red Crescent Medical Journal (2016)
Experts (# of related papers)
View all Related Experts
Farhad Bonakdar Hashmi (4)
Mohammad Hossein Yazdi (2)
Other Related Docs
9. Bivalent Flagellin Immunotherapy Protects Mice Against Pseudomonas Aeruginosa Infections in Both Acute Pneumonia and Burn Wound Models, Biologicals (2017)
10. Immune Responses of Mice Immunized With Hbsag Formulated in Naloxone/Alum Mixture: Comparison to Fendrix Vaccine, Hepatitis Monthly (2017)
11. Improvement of the Inactivated Sars-Cov-2 Vaccine Potency Through Formulation in Alum/Naloxone Adjuvant; Robust T Cell and Anti-Rbd Igg Responses, Iranian Journal of Basic Medical Sciences (2022)
12. A Survey on the Adjuvant Role of Naloxone Alone or Combined With Alum in Vaccination Against Fasciolosis in Balb/C Mice, Acta Parasitologica (2019)
13. Increasing of Methicillin-Resistant Staphylococcus Aureus Vaccine Potency, Using a Mixture of Alum-Naloxone: Augmentation of Humoral Immune Responses, Journal of Applied Biological Sciences (2015)
14. Formulation of a Recombinant Hiv-1 Polytope Candidate Vaccine With Naloxone/Alum Mixture: Induction of Multi-Cytokine Responses With a Higher Regulatory Mechanism, APMIS (2021)
15. High Prevalence of Multidrug-Resistant Pseudomonas Aeruginosa Carrying Integron and Exoa, Exos, and Exou Genes Isolated From Burn Patients in Ahvaz, Southwest Iran: A Retrospective Study, Health Science Reports (2024)
16. Evaluation of the Alum–Naloxone Adjuvant Activity Against Experimental Murine Leishmaniasis Due to L. Major, Journal of Parasitic Diseases (2016)
17. Naloxone Effects Against Cutaneous Leishmaniasis Caused by Leishmania Major Strain Mrho/Ir/75/Er in the Balb/C Mice, Infectious Disorders - Drug Targets (2023)
18. Immunological Evaluation of an Alginate-Based Conjugate As a Vaccine Candidate Against Pseudomonas Aeruginosa, APMIS (2015)
19. Induction of Specific Humoral Immune Response in Mice Against a Pseudomonas Aeruginosa Chimeric Pilq/Pila Protein, Reports of Biochemistry and Molecular Biology (2017)
20. Opioids and Viral Infections: A Double-Edged Sword, Frontiers in Microbiology (2016)
21. Dissection of the Cis-2-Decenoic Acid Signaling Network in Pseudomonas Aeruginosa Using Microarray Technique, Frontiers in Microbiology (2015)
22. Immunopotentiation of the Engineered Low-Molecular-Weight Pilin Targeting Pseudomonas Aeruginosa: A Combination of Immunoinformatics Investigation and Active Immunization, Molecular Immunology (2020)
23. Molecular Detection of Six Virulence Genes in Pseudomonas Aeruginosa Isolates Detected in Children With Urinary Tract Infection, Microbial Pathogenesis (2017)
24. Evaluation of the Immune Responses Following Co-Administration of Pilq and Type B-Flagellin From Pseudomonas Aeruginosa in the Burn Mouse Model, Microbial Pathogenesis (2018)